-
Mashup Score: 19Challenges with selecting therapy after failure of frontline treatments in R/R multiple myeloma - 2 month(s) ago
In this video, Noopur Raje, MD, Massachusetts General Hospital, Boston, MA, discusses the challenges faced by clinicians when selecting therapies for patients with multiple myeloma who have relapsed after frontline therapy. Dr Raje also elaborates on the optimal sequencing of T-cell directed immunotherapies and their potential inclusion in the frontline setting. This interview took place at the 20th International Myeloma Society (IMS) Annual Meeting, held in Athens, Greece. These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Source: www.vjhemonc.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 21Challenges with selecting therapy after failure of frontline treatments in R/R multiple myeloma - 2 month(s) ago
In this video, Noopur Raje, MD, Massachusetts General Hospital, Boston, MA, discusses the challenges faced by clinicians when selecting therapies for patients with multiple myeloma who have relapsed after frontline therapy. Dr Raje also elaborates on the optimal sequencing of T-cell directed immunotherapies and their potential inclusion in the frontline setting. This interview took place at the 20th International Myeloma Society (IMS) Annual Meeting, held in Athens, Greece. These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Source: www.vjhemonc.comCategories: General Medicine News, Onc News and JournalsTweet-
As March is #myelomaawarenessmonth, we wanted to raise awareness by sharing some great NEW content from #IMS2023 📣🩸 Challenges with selecting therapy after failure of frontline treatments in R/R #multiplemyeloma💡💉 @NoopurRajeMD Learn more 👉 https://t.co/Tl2j8YaRtm #MMsm https://t.co/6inrj1gFdS
-
As March is #myelomaawarenessmonth, we wanted to raise awareness by sharing some great NEW content from #IMS2023 📣🩸 Challenges with selecting therapy after failure of frontline treatments in R/R #multiplemyeloma💡💉 @NoopurRajeMD Learn more 👉 https://t.co/Tl2j8YaRtm #MMsm https://t.co/6inrj1gFdS